Literature DB >> 25938191

Single-step cloning-screening method: a new tool for developing and studying high-titer viral vector producer cells.

A F Rodrigues1,2, A S Formas-Oliveira1,2, M R Guerreiro1,2, H A Tomás1,2, P M Alves1,2, A S Coroadinha1,2.   

Abstract

This article describes a novel method merging the cloning of viral vector producer cells with vector titer screening, allowing for screening 200-500 clones in 2 weeks. It makes use of a GFP separated into two fragments, S10 and S11 (Split GFP), fluorescing only upon transcomplementation. Producer cells carrying a S11 viral transgene are cloned in 96-well plates and co-cultured with target cells stably expressing S10. During the period of clone expansion, S11 viruses infect S10 target cells reconstituting the GFP signal. Transcomplemented fluorescence data provide direct estimation of the clone's productivity and can be analyzed in terms of density distribution, offering valuable information on the average productivity of the cell population and allowing the identification of high-producing clones. The method was validated by establishing a retrovirus producer from a nude cell line, in <3 months, inserting three vector constructs without clone selection or screening in between. Clones producing up to 10(8) infectious particles per ml were obtained, delivering optimal ratios of infectious-to-total particles (1 to 5). The method was additionally used to evaluate the production performance of HEK 293 and HEK 293T cell lines demonstrating that the latter sustains increased titers. Finally, it was used to study genetic manipulation of glutathione metabolism in retrovirus production showing that changing cell metabolism steers higher vector expression with titer increases of more than one order of magnitude.This method is a valuable tool not only for cell line development but also for genetic manipulation of viral vector and/or producer cells contributing to advancing the field of viral gene therapy.

Entities:  

Mesh:

Year:  2015        PMID: 25938191     DOI: 10.1038/gt.2015.44

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  32 in total

1.  Quantitation of MLV-based retroviral vectors using real-time RT-PCR.

Authors:  M Carmo; C Peixoto; A S Coroadinha; P M Alves; P E Cruz; M J T Carrondo
Journal:  J Virol Methods       Date:  2004-08       Impact factor: 2.014

Review 2.  Production of retroviral vectors: review.

Authors:  Ana S Coroadinha; Leonor Gama-Norton; Ana I Amaral; Hansjorg Hauser; Paula M Alves; Pedro E Cruz
Journal:  Curr Gene Ther       Date:  2010-12       Impact factor: 4.391

3.  A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors.

Authors:  R Schucht; A S Coroadinha; M A Zanta-Boussif; E Verhoeyen; M J T Carrondo; H Hauser; Dagmar Wirth
Journal:  Mol Ther       Date:  2006-05-11       Impact factor: 11.454

4.  The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.

Authors:  A S Coroadinha; R Schucht; L Gama-Norton; D Wirth; H Hauser; M J T Carrondo
Journal:  J Biotechnol       Date:  2006-03-09       Impact factor: 3.307

5.  RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.

Authors:  Anna Stornaiuolo; Bianca Maria Piovani; Sergio Bossi; Eleonora Zucchelli; Stefano Corna; Francesca Salvatori; Fulvio Mavilio; Claudio Bordignon; Gian Paolo Rizzardi; Chiara Bovolenta
Journal:  Hum Gene Ther Methods       Date:  2013-08-03       Impact factor: 2.396

6.  Gene therapy finds its niche.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2011-02       Impact factor: 54.908

7.  Retroviral vector performance in defined chromosomal Loci of modular packaging cell lines.

Authors:  L Gama-Norton; S Herrmann; R Schucht; A S Coroadinha; R Löw; P M Alves; C C Bartholomae; M Schmidt; C Baum; A Schambach; H Hauser; D Wirth
Journal:  Hum Gene Ther       Date:  2010-08       Impact factor: 5.695

8.  High-titer packaging cells producing recombinant retroviruses resistant to human serum.

Authors:  F L Cosset; Y Takeuchi; J L Battini; R A Weiss; M K Collins
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells.

Authors:  Leonor Gama-Norton; Lacramioara Botezatu; Sabrina Herrmann; Matthias Schweizer; Paula Marques Alves; Hansjoerg Hauser; Dagmar Wirth
Journal:  Hum Gene Ther       Date:  2011-06-13       Impact factor: 5.695

10.  Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real-time quantitative PCR.

Authors:  Laurent Bodin; Philippe H Beaune; Marie-Anne Loriot
Journal:  J Biomed Biotechnol       Date:  2005
View more
  3 in total

1.  Evaluation of Structurally Distorted Split GFP Fluorescent Sensors for Cell-Based Detection of Viral Proteolytic Activity.

Authors:  Miguel R Guerreiro; Ana R Fernandes; Ana S Coroadinha
Journal:  Sensors (Basel)       Date:  2020-12-23       Impact factor: 3.576

Review 2.  Lentiviral Vector Bioprocessing.

Authors:  Christopher Perry; Andrea C M E Rayat
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

3.  LentiPro26: novel stable cell lines for constitutive lentiviral vector production.

Authors:  H A Tomás; A F Rodrigues; M J T Carrondo; A S Coroadinha
Journal:  Sci Rep       Date:  2018-03-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.